Get the free Exclusivity Summary NDA # 203922 - accessdata fda

This document outlines the exclusivity determination for the New Drug Application (NDA) for Sodium Nitrite Injection, detailing the approval process and requirements under the FDA guidelines.

How to fill out exclusivity summary nda 203922

How to fill out Exclusivity Summary NDA # 203922

1. Begin by reading the title and purpose of the Exclusivity Summary NDA # 203922 to understand its intent.
2. Fill in the date at the top of the document.
3. Enter the names of the parties involved in the agreement in the designated fields.
4. Specify the nature of the confidential information that will be covered by the NDA.
5. Outline the obligations of each party regarding the handling of confidential information.
6. Define the duration of the exclusivity period and the NDA's validity.
7. Include any exceptions to confidentiality obligations if applicable.
8. Review the document for completeness and clarity.
9. Have both parties sign and date the NDA to execute the agreement.

Who needs Exclusivity Summary NDA # 203922?

1. Businesses or individuals entering into negotiations that require protection of confidential information.
2. Entities sharing sensitive data to ensure that both parties adhere to agreed confidentiality terms.
3. Anyone seeking to establish trust and clarity in a business relationship involving proprietary information.

People Also Ask about

Is sodium nitrate regulated?

From an industrial perspective, it is the most important nitrite salt. It is a precursor to a variety of organic compounds, such as pharmaceuticals, dyes, and pesticides, but it is probably best known as a food additive used in processed meats and (in some countries) in fish products.

What is a sodium nitrite injection used for?

Sodium nitrite and sodium thiosulfate injection are used together to treat cyanide poisoning. Cyanide poisoning is a life-threatening condition that requires immediate medical attention.

Is sodium nitrite still used?

It reacts with combustible and reducing materials. This generates fire and explosion hazard. The substance can be absorbed into the body by inhalation of its aerosol and by ingestion. The substance is irritating to the eyes, skin and respiratory tract.

Is sodium nitrate approved by the FDA?

Added sodium nitrate has strict limits. Per FDA, sodium nitrite cannot exceed 200 ppm and sodium nitrate cannot exceed 500 ppm in the finished product. The parts per million (ppm) signifies the number of nitrates and nitrites in a curing salt.

Is sodium nitrate FDA approved?

Both nitrate and nitrite are substances approved by FDA and USDA for use in foods. Levels of nitrate and nitrite used in meat products are carefully controlled by Federal laws and monitored by the USDA or state government officials.

For pdfFiller’s FAQs

What is Exclusivity Summary NDA # 203922?

Exclusivity Summary NDA # 203922 is a submission to the FDA that provides a summary of the exclusivity status of a drug application, consolidating important information about market exclusivity rights.

Who is required to file Exclusivity Summary NDA # 203922?

The sponsor or applicant of the New Drug Application (NDA) seeking market exclusivity is required to file Exclusivity Summary NDA # 203922.

How to fill out Exclusivity Summary NDA # 203922?

To fill out Exclusivity Summary NDA # 203922, the applicant must provide relevant details about the drug's approval, including the exclusivity period, patent information, and any previous extensions or amendments.

What is the purpose of Exclusivity Summary NDA # 203922?

The purpose of Exclusivity Summary NDA # 203922 is to inform the FDA and the public about the exclusivity rights granted for a drug, helping to manage market competition and patent protection.

What information must be reported on Exclusivity Summary NDA # 203922?

Information that must be reported includes the NDA number, product name, the date of approval, duration of exclusivity, related patent numbers, and any prior exclusivity or extensions.